Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH
Clinical trial NCT07187193 · RECRUITING
Trial details
- NCT number
- NCT07187193
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-12
- Primary completion
- 2027-04-12
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.